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Costus pictus is found to have antidiabetic activity, but the real mechanism of action and the potent bioactive molecule 
responsible is still unknown. This work aims to identify the potential mechanism of action of the partially purified antidiabetic 
extract of C. pictus extract. The purified methanol extract of C. pictus was prepared and the presence and isolation of protein were 
done by ammonium sulfate precipitation. The carbohydrate enzyme, -amylase, and -glucosidase inhibition activity of the crude, 
protein, and nonprotein part of the extract were investigated in vitro. Glucose-induced insulin secretion assay and calcium levels in 
the cytoplasm were also evaluated using pancreatic cell lines. The effect of GSK3β gene expression was studied in RIN5MF cells 
treated with crude extract of C. pictus. The crude methanol extract showed the presence of several classes of compounds, with 
significant levels of polyphenols and flavonoids. A protein of 25 kDa molecular weight was found in the crude extract. Protein and 
crude extract showed enzyme inhibitory activity, glucose uptake, and increased calcium uptake, and increased insulin secretion. 
The effect was more in crude extract than protein and nonprotein parts. Moreover, the crude extract reduced the gene expression of 
GSK3β, which may be one of the possible mechanisms by which the antidiabetic property of C. pictus relies upon. The results 
showed that the antidiabetic and insulin secretagogue property of C. pictus involves multiple mechanisms and requires the 
involvement of both phytochemicals as well as the protein present in it.  
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Diabetes, a chronic metabolic disease is associated with 
elevated fasting blood glucose levels and impaired 
insulin production
1
 or the body cannot utilize the 
insulin. This deadly disease makes millions of people 
suffer worldwide and type 2 diabetes mellitus (T2DM) 
is the most prominent form accounting for more than 
80% of the total cases. Insulin, a peptide hormone 
identified and isolated in 1921 is still being used as an 
effective medication for combating diabetes mellitus
2
. 
Insulin stimulates different cells to uptake glucose from 
the circulatory system. The underutilization of insulin 
leads to insulin resistance, which is characterized by 
the inability of cells to respond to the circulating 
insulin
3
, leading to diabetes. 
Plants have been widely used since ancient times for 
the treatment of diabetes. Insulin-like substances/ 
proteins isolated from plant tissues, yeast, and fungi are 
found to be capable of producing a profound beneficial 
effect on carbohydrate metabolism
4
. The occurrence of 
such protein in plants did not evoke much interest 
among the scientific community until the presence of 
insulin-like peptides was confirmed from the fruits of 
Momordica charanti which is rich in nutrients and 
phytochemicals
5
. From the developing fruits of cowpea, 
insulin-like protein, involved in carbohydrate transport 
with similarity to the amino acid sequence of bovine 
insulin was identified
6
. A similar protein was also 
isolated from the antidiabetic plant Bauhinia variegate, 
which was found to have significant involvement in 
carbohydrate metabolism
7
. Reports indicate that insulin-
like protein was purified from Costus igneus, which 
showed cross-reactivity with murine anti-insulin 
antibodies, and was purified by affinity chromatography. 
The protein showed hypoglycemic activity and a 
significant decrease in blood glucose levels. C. pictus 
(insulin plant), a native of Mexico is utilized for the 
treatment of diabetes, cancer, and inflammation
8,9
. The 
rhizomes of C. pictus are eaten by the people cooked, 
roots form a major constituent in tonic and anthelmintic 
medicines, and leaves are consumed by the patients for 
curing diabetes
10








hypoglycemic activity of C. pictus leaves was 
undertaken by Arjuna Natural Extracts LTD, Kerala, 
India, and found that the extract obtained from the plant 
had considerable hypoglycaemic activity
10
. Though  
C. pictus is used for reducing blood sugar, the exact 
molecular mechanism by which the effect is exerted is 
largely unknown.  
In this, study the presence of any kind of protein  
in the partially purified methanolic extract of C. pictus 
is evaluated. The effect of the extract and protein  
on carbohydrate metabolic enzyme inhibition was 
investigated with -amylase and -glucosidase.  
A comparative study on glucose uptake was done 
with crude methanolic extract, protein, and nonprotein 
part using intestinal epithelial cell lines (HT 29). 
Glucose-induced insulin secretion assay, calcium 
levels in the cytoplasm, have been investigated for the 
antidiabetic properties of the extracts.  
 
Materials and Methods 
 
Chemicals 
DMSO, McCOY’s 5A medium, RPMI-1640, Fetal 
Bovine Serum (FBS), antibiotics were purchased from 
Hi-Media, India. 2-[N-(-7-Nitrobenz-2-oxa-1, 3-diazol-
4-yl) amino]-2-deoxy-d-glucose (2NBDG) was 
purchased from Sigma chemicals, USA. Fura-2AM  
for calcium staining was procured from Invitrogen, 
USA. RIN5F cells, HT 29 cells, Miapaca cells were 
purchased from the National Centre for Cell Sciences 
(NCCS), Pune, India. Previously A composition for 
treating diabetes and dyslipidemia obtained from the 
extract of C. pictus plant and a method of preparing the 
same was patented (Merina Benny Antony., Inventor-. 
US Patent (No. US 9981000, dated May 29, 2018). 
 
Extraction of C.pictus 
C. pictus was collected from the nursery of Arjuna 
Naturals Extracts Ltd, Alwaye, Kerala, India. C. pictus 
was extracted with 90% methanol by refluxing. The 
residue obtained was cooled, filtered, and concentrated. 
The extract was evaluated for the presence of acids, 
carboxylic, and oxalic acid using HPLC
11
. Oxalic acid, 
which contributes towards the sour taste of the plant was 
removed to obtain a purified methanol extract of  
C. pictus (MECP), which was used for the evaluation of 
antidiabetic activity in vitro. 
 
Preliminary phytochemical analysis 
The purified methanol extract, MECP was found to 
be brown with a moisture content of 4.8%. The extract 
was found to be soluble in both methanol and water. 
The extract was found to contain proteins (49%), 
Carbohydrates (33%), and fats (2.5%), respectively
11
. 
The extract was also analyzed qualitatively for the 
presence of phenolic compounds (Lead acetate test), 
flavonoids (Alkaline reagent test), tannins (Ferric 
chloride test), steroids, triterpenoids (Salkowski’s test), 
saponins (Froth test), cardiac glycosides (Keller 





Determination of polyphenols and flavonoids in MECP  
and NPCP 
The total phenol content was determined by the 
Folin-Ciocalteu method. To the different concentration 
of the samples (adjusted using methanol) 80 µL of 
Folin-Ciocalteu reagent and 200 µL of Na2CO3 was 
added. The mixture was mixed well and absorbance 
was determined after 90 min at 725 nm against 
standard Gallic acid. The total phenolic content of the 
extract was expressed as mg gallic acid equivalence/g 
of the extract. For total flavonoid estimation, the 
extract in DMSO was mixed with 1.5 mL of 95% 
alcohol, 0.1 mL of 10% aluminum chloride hexahydrate 
(AlCl3), 0.1 mL of 1 M CH3COOK, and 2.8 mL of 
distilled water. After incubation at room temperature for 
40 min, the reaction mixture absorbance was measured 
at 415 nm on a spectrophotometer (Shimadzu UV-vis-
Spectrophotometer, model 2600). The total flavonoid 
content of the extract was expressed mg quercetin 




Isolation of proteins from MECP 
Methanolic extract of C. pictus was mixed with  
10 volumes of cold 10% TCA in acetone. The mixture 
was vortexed and incubated for 3 h at −200C or 
overnight. The same volume of cold acetone was 
added, vortexed, and stored at −20C for 10 min and 
centrifuged at 15000 g for 5 min. The supernatant was 
removed and the pelleted protein (PCP) obtained was 
air-dried. The concentration of protein was estimated 
using the Bradford assay
14
. The protein obtained by 
precipitation was subjected to SDS–PAGE by the 




α amylase inhibition assay 
The -amylase repressing activity of MECP, PCP, 
and NPCP was evaluated by the strategy represented 
earlier with slight modification
16
. The reaction 
mixture containing 50 μL phosphate buffer (50 mM, 
pH= 6.8), 10 μL -amylase (10 U/mL) and 20 μL of 
varied concentrations of extracts were pre-incubated 
at 37C for 10 min. Then 20 μL soluble starch 
(0.05%) was added as a substrate and incubated 




further at 37C for fifteen min. The reaction was 
stopped by adding 20 μL 1N HCl, followed by the 
addition of 100 μL iodine. The absorbance was read at 
620 nm using a Multimode Reader. Each experiment 
was performed in triplicates and the inhibitory effect 











where, A is absorbance. 
 
α-Glucosidase inhibition assay  
The reaction mixture containing 50 μL phosphate 
buffer (50 mM, pH-6.8), 10 μL -glucosidase  
(1 U/mL), and 20 μL of varying concentrations of the 
extracts were pre-incubated at 37C for fifteen min. 
The substrate, p-nitrophenyl-α-D-Glucopyranoside 
(PNPG; 1 mM; 20 μL) was added and incubated at 
37C for thirty min. The reaction was stopped by 
adding sodium carbonate (50 μL; 0.1 M). The 
absorbance was measured at 405 nm. Acarbose at 
numerous concentrations (200-1000 μg/mL) was used 
as the standard. The result was expressed as percentage 















Glucose uptake studies on MECP, PCP, and NPCP on HT 29 cells 
using 2NBDG 
The level of glucose uptake in the presence of 
MECP, PCP, and NPCP was carried out using a 
fluorescent structural analogue of glucose. Briefly, 
McCoy's 5A medium supplemented with 10% fetal 
bovine serum and antibiotics in 5% CO2 at 37C 
served as the medium for maintenance of Intestinal 
epithelial cell lines, HT29. After attaining 70% 
confluency, cells were seeded in 96 well plates with 
BSA (1 mg/mL) and 80 µM fluorescent analog, 
2NBDG (Invitrogen) in presence of different 
concentrations of MECP, PCP, and NPCP for 60 min. 
For stimulation experiments, 100 µL insulin was 
added along with extracts. The cells were washed and 
plates and the absorbance was were read at an ex/em 




Glucose-induced insulin secretion in the presence of MECP, 
PCP, and NPCP in RIN-m5Fcells 
RIN-m5F cells were cultured at 37C in a humidified 
atmosphere of 5% CO2− in the air in RPMI-1640 
containing 10% FBS and antibiotics. Cells were seeded 
in a 48 well plate and allowed to attach 48 h before the 
acute tests. Wells were washed three times with KRB; 
115 mM NaCl, 4.7 mM KCl; 1.3 mM CaCl2.  
1.2 mMKH2PO4, 1.2 mM MgSO4 24 mM NaHCO3,  
10 mM HEPES, 1 g/mL BSA. A 1 mM glucose; pH 7.4. 
Cells were and pre-incubated for 1 h at 37C followed 
by incubation with KRB with 4.5 mM glucose and 
MECP, PCP, and NPCP for 1 h. Aliquots were removed, 
centrifuged at 2000 rpm for 5 min at 4C, and assayed 




Estimation of Intracellular calcium levels in the presence of 
MECP, PCP, and NPCP in Miapaca cells 
The intracellular calcium concentration, [Ca
2+
], 
was measured using Fura-2AM (Molecular Probes, 
Invitrogen). Islets were incubated in calcium-free 
HBSS with 5 µM FURA-2AM at 37C for 30 min
20
. 
After washing (2x) with calcium-free HBSS, islets 
were suspended in complete HBSS and treated with 
various concentrations of MECP, PCP, and NPCP for  
60 min. fluorescence was measured in the multiplate 
reader at an emission wavelength of 500 nm for dual 
excitation wavelength at 340 and 380 nm. The Ca
2+
 




Expression AKT, GSK3β, IRS 1 mRNA in MECP, PCP and 
NPCP treated RIN-m5F cells 
Total RNA was isolated from control and treated 
cells by Trizol reagent (Himedia) as described by the 
manufacturer’s instructions. cDNA was synthesized 
by adding 1 ng of RNA to the 5X cDNA synthesis 
buffer (4 µL), dNTP Mix (2 µL) RNA primer (1 µL), 
RT Enhancer (1 µL) Verso Enzyme Mix (1 µL) and 
nuclease-free water (20 µL) using Thermo Scientific 
Verso cDNA Synthesis Kit. PCR was done by using 
GoTaq Green Master Mix in thermal cycler using the 
following primer sequences GSK3β (Forward 5–
GGAACTCCAACAAGGGAGCA-3 Backward 5–
TTCGGGGTCGGAAGACCTTA-3)., AKT (5-TCA 
CCTCTGAGACCGACACC TCACCTCTGAGACC 
GACACC-3, 5-ACTGGCTGAGTAGGAGAACTGG-
3), Insulin receptor1 (5-AGTGGCCATGGCT CCACA-
3, 5-TTGCCACCCATGCAGAT-3 GAPDH was 
used as an endogenous control. The finished PCR 
product was run on 1.5% agarose and analyzed using 




Preliminary phytochemical analysis 
Preliminary phytochemical screening was done to 
identify the different classes of components present in 




the C. pictus methanolic extract. Results showed that 
the MECP contains different classes of compounds viz 
polyphenols, flavonoids, proteins, tannins, steroids, 
triterpenoids, saponins, and cardiac glycosides, etc. 
Figure 1 indicates that MECP contains a higher amount 
of polyphenols than flavonoids (120 and 56 µg/mg 
sample), while after removal of proteins showed a 
total phenol content of 129.3 µg/mg and flavonoid 
content of 39.9 µg/mg sample, respectively. Cold 
TCA treatment of 5g MECP yielded 1.2 g of the 
precipitate. Bradford assay showed that the protein 
concentration was 0.46±0.21 mg/mg TCA precipitate. 
Electrophoresis of the precipitate showed the presence 
of a single band of protein with an approximate 
molecular weight 25 kDa. These results suggest that 
the MECP contains components conjugated to proteins 
probably in the form of glycoproteins as well as many 
biologically active secondary metabolites that 
contribute towards its antidiabetic activity.  
 
α amylase and α glucosidase Enzyme inhibitory activity 
The crude methanol extract of C.pictus, MECP 
showed a significant α amylase inhibitory effect with 
an IC50 value of 33.53 µg/mL. The amylase inhibitory 
activity of protein isolated from C. pictus, PCP also 
showed profound amylase inhibition ranged from 
29.66 to 53.64%, but at mg concentration (Fig. 2A). 
PCP showed maximum inhibition of 53.64 % at  
2 mg/mL. The methanol extract obtained after protein 
isolation, NPCP inhibited α amylase activity at higher 
concentrations, with an IC50 value of 1.14 mg/mL. 
The in vitro α glucosidase inhibition studies 
demonstrated that MECP inhibited the enzyme in  
in vitro conditions. 6 mg/mL of the extract showed 
inhibition of about 80%. PCP had profound 
concentration-dependent α glucosidase inhibitory 
activity, with the highest concentration of 2 µg 
showed maximum inhibition of nearly 61.18%  
(Fig. 2B). The percentage inhibition varied from  
35.8-61.18% from the lowest concentration to the 
highest concentration. NPCP showed higher inhibition 
(IC50 value of 95.36 µg/mL) than PCP. The inhibitory 
effect of the extract was comparable with that 
obtained for standard acarbose. It has been shown that 
NPCP had higher activity than acarbose.  
 
Increased glucose uptake by HT 29 cells in the presence of 
MECP, PCP, and NPCP 
Differentiated HT29 cells were incubated with or 
without insulin along with various fractions. MECP 
and PCP showed a dose-dependent increment in 
glucose uptake, which was significantly greater than 
NPCP part. However, higher concentrations of PCP 
showed maximal glucose uptake compared to both 
MECP and NPCP. In the presence of insulin, MECP and 
PCP showed a dose-dependent increment in glucose 
uptake as evidenced by higher fluorescence (Fig. 3).  
 
Effect on GLUT 2 translocation in a colon cell line, HT-29cells 
treated with MECP, NPCP, and PCP  
Tissues whose function is regulated by glucose also 
possess particular glucose transporters, GLUT 4 in 
adipocytes and GLUT 2 in tissues secreting glucose 
into the blood (liver, small intestine, and proximal 
tubular cells of the kidney) as well as GLUT 2 in the 
β cells of the islets of Langerhans. We used HT 29, 
intestinal epithelial for the translocation  study. HT29 
cells were treated with an increasing concentration  
of MECP, NPCP, and PCP. Cells were treated with 
GLUT-2 primary antibody and then with Alexa  
fluor conjugated secondary antibody which gives 
 
 
Fig. 1 — Total polyphenols, flavonoids in MECP , and NPCP, and the electrophoresis of protein isolated from MECP. A: Total polyphenols 
and flavonoids, B: Protein isolated from the crude extract. Results are expressed as mean ± SEM of three independent experiments. 
MECP: Methanol extract of C.pictus, NPCP: Non-protein part after protein removal 




fluorescence. The intensity of the fluorescence was 
found to be increased in a dose-dependent manner when 
treated with MECP and NPCP parts. While PCP showed 
lower translocation of GLUT 2 in HT 29 cells.  
 
MECP induces insulin secretion from RIN5MF cells 
MECP showed a significant dose-dependent 
increment in insulin secretion from mouse pancreatic 
cell lines, RIN5MF cells under-stimulated glucose 
concentration (Fig. 4). PCP, at 20 µg/mL showed 
increased insulin secretion, comparable to that of 
NPCP, but significantly lower than that of MECP. 
Glibenclamide was used as standard and found to 
have a lower effect on insulin secretion from 
RIN5MF cells compared to that of MECP. 
 
PCP increased intracellular calcium in the pancreatic cell, MIA 
PaCa-2 than MECP and NPCP 
There was an increase in calcium levels when the 
extracellular glucose concentration was increased up to 
16.7 mM. Under the stimulating concentration of 
glucose, a dose-dependent increment in intracellular 
calcium levels was noticed in the presence of PCP in a 
dose-dependent manner (Fig. 5). MECP exhibited narrow 
variation in calcium uptake and NPCP part showed very 
less calcium uptake. 
 
 
Fig. 2 — In vitro α (A) amylase; (B) glucosidase  inhibitory activity of MECP, NPCP, and PCP. Results are expressed as mean ± SEM of three 
independent experiments. MECP: Methanol extract of C.pictus, NPCP: Non-protein part after protein removal, PCP: Protein isolated from C. pictus 
 







Fig. 3 — Effect of MECP, NPCP, and PCP on glucose uptake in HT 29 cells. Pictures are the representation of three separate experiments 
(magnification 20x). Results are expressed as mean ± SEM of three independent experiments. MECP: Methanol extract of C.pictus, NPCP: 




Fig. 4 — Effect of MECP, NPCP, and PCP on glucose-stimulated insulin secretion in RIN5F cells and intracellular calcium  
levels in Miapaca cells. Pictures are the representation of three separate experiments (magnification 20x). Results are expressed as  
mean ± SEM of three independent experiments. A: Intracellular Calcium levels; B: Insulin secretion. MECP: Methanol extract of  
C.pictus, NPCP: Non-protein part after protein removal, PCP: Protein isolated from C. pictus 






Fig. 5 — Effect of MECP, NPCP, and PCP on glucose-stimulated intracellular calcium levels in MiaPaca cells. Pictures are the 
representation of three separate experiments (magnification 20x). MECP: Methanol extract of C.pictus, NPCP: Non-protein part after 
protein removal, PCP: Protein isolated from C.pictus 
 
Discussion 
Diabetes is a major health problem for millions of 
people worldwide, which becomes chronic due to the 
deficiency of insulin/resistance or both. Presently  
this condition is treated by insulin injection or by 
other synthetic chemicals which often leads to 
hypoglycemia. A natural drug that could prevent 
diabetes without creating hypoglycemia is quite 
interesting. India has a well-defined indigenous 
medical system that utilizes plant products or derived 
components for curing various diseases. C. pictus is 
one such plant used by many patients to cure diabetes. 
Previous reports indicate that C. pictus extract 
lowered toxicity in rats treated with 200 mg/kg  





According to the survey 
conducted by Arjuna Natural Extracts, Kerala, India, 
it was found that that C. pictus was widely used by 
the population of Kerala as an antidiabetic medicine 
without being prescribed or without any proper 
scientific authentication of the species consumed. It 
was also known that many people used C. speciosus 
without knowing its adverse toxicity and other 
inflammatory reactions. About 97.8% of people had a 
decrease in fasting blood sugar and more than 70% 
people found a decrease in postprandial sugar level, 
while 77.8% of patients did not notice any 
complications after consuming the plant, but a few 
people complained about gastric discomfort or 
acidity, which may be due to higher concentration of 
plant material
23
. Though the C. pictus extract shows 
significant antidiabetic activity, the molecular 
mechanism by which it acts remains unclear. This 
study was designed to evaluate the presence of 
proteins in C. pictus extract, and its effect on the 
insulin release and inhibition of carbohydrate 
metabolism enzymes as well as the preliminary 
molecular mechanism of antidiabetic activity in 
pancreatic cell lines. The results showed that the 
crude methanol extract of C. pictus (MECP) contains 
several classes of compounds, viz. protein, saponins, 
tannins, steroids, triterpenoids, polyphenols, and 
flavonoids. Quantitative analysis showed the 
polyphenol levels were much higher than flavonoids. 
Ammonium sulfate precipitation showed the presence 
of a protein with a molecular weight of 25 kDa. 
Previous studies showed that C. pictus leaves contain 
the presence of fibers, steroids α-tocopherol, 
ergastanol, terpenoid lupeol, and stigmasterol
24
. These 
observations are comparable with the results obtained 
from our studies. Research across the world has 
proved that secondary metabolites isolated and 
purified from plants have antidiabetic effects in 
various experimental animal models
25-27
.  
Experiments were carried out to evaluate the effect 
of Crude (MECP), Protein (PCP), and the extract 




obtained after the removal of protein (NPCP) portion 
of C. pictus. -amylase enzyme activity was 
significantly reduced by MECP at μg concentration 
range and the effect was comparable with that 
obtained for acarbose. Protein isolated from C. pictus 
also showed an inhibitory effect, but a higher 
concentration was required for even 60% inhibition, 
while NPCP showed a maximum effect of 80% 
inhibition at a concentration of 4 mg/mL which is 
much higher than that of MECP. -glucosidase 
inhibitory studies showed that NPCP with profound 
effects at μg concentration, while MECP, PCP, and 
acarbose showed an inhibitory effect at higher 
concentrations. This varied effect indicates that both 
protein and other phytochemicals are working in 
coordination in the antidiabetic activity of C.pictus. 
Glucose uptake studies using human colon cancer 
cell lines, HT-29 cells showed that PCP increased the 
glucose uptake by the cells in a concentration-
dependent manner, but found to be lesser than insulin 
which showed a very high effect. Glucose uptake in 
the presence of MECP was lesser, while the presence 
of NPCP showed a significantly lower uptake. This 
result showed that the protein present in C. pictus may 
have some insulin-like activity which contributes to 
the glucose uptake effect of MECP. 
Insulin secretion from mouse pancreatic cells, RIN-
m5F was increased by the treatment with NPCP and 
MECP compared to the PCP. The PCP influences the 
intracellular calcium dynamics in pancreatic cells, 
MIA PaCa-2 compared to NPCP. The Non protein part 
showed a significant effect in the translocation of 
GLUT-2 in HT-29 cells, an effect more profound than 
PCP. Gene expression analysis showed that levels of 
AKT were found to be stable in control and treated 
groups, while the expression of GSK3β gene was 
found to be decreased in MECP treated groups in a 
dose-dependent manner. GSK3β, a modulator of 
glycogen metabolism is also involved in multiple 
roles in regulating protein synthesis and cell 
differentiation
28
. GSK3β is a negative regulator of the 
insulin signaling pathway and is involved in insulin 
resistance, and this gene is now considered to be a 
potent target for the intervention and control of type 2 
diabetes
29
. GSK-3b is the most potent inhibitor of 
Glycogen Synthase and subsequent glycogenesis and 
is therefore considered as a promising target for 
diabetes treatment
30
. Studies report that insulin 
activates p13K/Akt and reduces glycogen synthase 
activity mediated through GSK3β
31
. IRS-1 gene 
expression was found to be increased in cells treated 
with varying concentrations of C. pictus extract  
(Fig. 6). Earlier studies showed that the methanol 
extract of C. pictus elevated the GLUT4 mRNA 
expression compared to the non-treated controls. 
Experiments also prove that when cells were  
treated with the extract, modulated IRb, and PI3K 
protein expressions equivalent to that of positive 
controls
32
. Apart from protein, extract from MECP 
showed the presence of polyphenolic components and 
flavonoids, which are capable of scavenging free 
radicals and chelate metals. Phytochemicals in 
C.pictus, especially the polyphenols and flavonoids 
can reduce the complications of diabetes by 
modulating multiple molecular pathways by 
maintaining blood glucose levels, reduce glucose 
uptake, and enhance insulin secretion as well as 





The outcome of the present study showed that  
C. pictus methanol extract can reduce diabetic 
conditions. Both protein and the nonprotein part, 
containing several bioactive secondary metabolites 
contribute toward this activity. C. pictus extract was 
found to induces antidiabetic activity through 
different mechanisms which include the inhibition of 
carbohydrate digesting enzymes, enhance insulin 
 
 
Fig. 6 — Expression levels of Akt, GSK3β, IRS1 in RIN 5 cells 
treated with MECP. Pictures are the representation of three 
separate experiments 




secretion from islets, modulation of glucose uptake by 
the cells, and inhibition of GSK3β gene expression.  
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